Last reviewed · How we verify
RX0041-002
At a glance
| Generic name | RX0041-002 |
|---|---|
| Sponsor | Pharmaceutical Project Solutions, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function (PHASE1)
- PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function (PHASE1)
- Topical Anesthetic for Procedures Through the Nose (PHASE3)
- Phase I Pharmacokinetic Study of RX0041-2 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |